Optimized vs. Standard Automated Peritoneal Dialysis Regimens (OptiStAR): study protocol for a randomized controlled crossover trial

BACKGROUND: It has been estimated that automated peritoneal dialysis (APD) is currently the fastest growing renal replacement therapy in the world. However, in light of the growing number of diabetic patients on peritoneal dialysis (PD), the unwanted glucose absorption during APD remains problematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergling, Karin, de Arteaga, Javier, Ledesma, Fabián, Öberg, Carl Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285558/
https://www.ncbi.nlm.nih.gov/pubmed/32528722
http://dx.doi.org/10.1186/s40814-020-00620-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285558/
https://www.ncbi.nlm.nih.gov/pubmed/32528722
http://dx.doi.org/10.1186/s40814-020-00620-2

Ejemplares similares